Article Text

PDF
Exocrine function in primary Sjögren syndrome: natural course and prognostic factors
  1. K Haldorsen1,
  2. K Moen1,
  3. H Jacobsen2,
  4. R Jonsson1,
  5. J G Brun3,4
  1. 1
    Broegelmann Research Laboratory, The Gade Institute, University of Bergen, Bergen, Norway
  2. 2
    Department of Otolaryngology/Head and Neck Surgery, Haukeland University Hospital, Bergen, Norway
  3. 3
    Section for Rheumatology, Institute of Medicine, University of Bergen, Bergen, Norway
  4. 4
    Department of Rheumatology, Haukeland University Hospital, Bergen, Norway
  1. K Haldorsen, Broegelmann Research Laboratory, The Gade Institute, University of Bergen, Armauer Hansen Building, Haukelandsveien 28, N-5021 Bergen, Norway; karstein.haldorsen{at}med.uib.no

Abstract

Objectives: Few studies have addressed the natural course of, or prognostic factors for the salivary and lacrimal function in primary Sjögren syndrome (SS). Except for the early stages, glandular function has been seemingly stable, and SS A antigen (SSA) seropositivity and hypocomplementemia may predict a decline in the van Bijsterveld score. The aim of the present study was to assess the natural course of the exocrine function in a larger cohort based on the American–European consensus criteria for SS, and to address possible predictive factors for a declining exocrine function.

Methods: We performed a retrospective cohort study. A total of 141 patients were investigated with the Schirmer I test and unstimulated whole saliva (UWS). Historical data regarding these tests and focus score were collected from the files of 111 patients. Median time from diagnosis to follow-up investigation was 5.0 years.

Results: Median UWS was unchanged during follow-up. Median Schirmer I test improved from 5.0 to 7.0 mm/5 min (p<0.05). Present Schirmer I test was associated with historical high IgG and IgA, positive SSA and SS B antigen (SSB) tests and high focus score, and present UWS with historical low C3/C4. Logistic regression identified high focus scores (odds ratio (OR) = 1.343), and low UWS (OR = 0.692) as factors predicting a 30% or more worsening of the Schirmer I test. High focus scores (OR = 1.488) predicted a 30% or more worsening of the UWS.

Conclusion: We confirmed previous studies showing a stable or slightly improved exocrine function over time. High focus scores and low UWS were identified as independent predictors of a worsened exocrine function.

Statistics from Altmetric.com

Footnotes

  • Competing interests: None declared.

  • Funding: This project was supported by a grant from the Reidun Aasgård Foundation, Helse Vest, the Strategic Research Program at Helse Bergen, and a grant from University of Bergen regarding rheumatology research.

  • Ethics approval: The study was approved by the Regional Committee for Medical Research Ethics, and all patients provided written informed consent before inclusion.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.